Globeflex Capital L P Biomarin Pharmaceutical Inc Transaction History
Globeflex Capital L P
- $592 Million
- Q3 2025
A detailed history of Globeflex Capital L P transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Globeflex Capital L P holds 8,719 shares of BMRN stock, worth $472,744. This represents 0.08% of its overall portfolio holdings.
Number of Shares
8,719
Previous 1,906
357.45%
Holding current value
$472,744
Previous $104,000
353.85%
% of portfolio
0.08%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
683Shares Held
189MCall Options Held
1.31MPut Options Held
1.09M-
Black Rock Inc. New York, NY22.7MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.01 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$826 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$796 Million0.46% of portfolio
-
Viking Global Investors LP12.3MShares$666 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...